Global CRO Announces Extension Agreement for OmniComm’s TrialOne


Applied Clinical Trials

A global CRO has expanded its existing partnership with OmniComm Systems, Inc., a global provider of clinical data management technology. Under this partnership, this CRO has announced a $7.8 million extension agreement for OmniComm’s TrialOne and will utilize OmniComm’s system to ensure regulatory compliance and bring greater operational efficiency, speed, and quality to the clinical research process within its clinics.

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.